Therapeutic approaches to neuroleptic-induced tardive dyskinesias.
D002090:Butyrophenones / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D010276:Parasympatholytics / Q000009:adverse effects; D012110:Reserpine / Q000627:therapeutic use; D013997:Time Factors; D014149:Tranquilizing Agents / Q000009:adverse effects*
D002090:Butyrophenones; D010276:Parasympatholytics; D014149:Tranquilizing Agents; D012110:Reserpine